Literature DB >> 17456936

Lipoprotein(a) as a risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus.

Rupali Chopra1, Jaison G Saramma, John Mary, Abraham Rebecca.   

Abstract

AIMS: To estimate serum lipoprotein(a) [Lp(a)] levels in patients with type 2 diabetes mellitus with and without diabetic retinopathy and to determine the correlation, if any, between serum Lp(a) levels and severity of diabetic retinopathy.
MATERIALS AND METHODS: The study included a total of 200 patients of type 2 diabetes mellitus out of which 100 patients who had no retinopathy served as the control group and 100 patients with diabetic retinopathy formed the study group. A detailed fundus examination was done with dilated pupil. The Lp(a) levels were measured quantitatively in fasting venous samples by an immunoturbidimetric method using commercially available kits (Clonital). STATISTICAL ANALYSIS USED: Group comparisons involving qualitative measures were carried out using Chi square test. ANOVA procedure was applied for comparing group means. Logistic regression analysis was performed for independent factors associated with diabetic retinopathy.
RESULTS: The average Lp(a) levels in the study group (68.5 mg/dl) were significantly higher than in the control group (25.1 mg/dl) (P 0.001). The Lp(a) levels were found to increase with increasing severity of diabetic retinopathy.
CONCLUSIONS: Serum Lp(a) levels are significantly raised in patients with diabetic retinopathy as compared to those with no retinopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456936     DOI: 10.4103/0301-4738.31939

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  4 in total

1.  Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications.

Authors:  Radhakrishnan Chandni; Kollengode Parameswaran Ramamoorthy
Journal:  World J Diabetes       Date:  2012-05-15

2.  Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.

Authors:  Haoliang Wang; Jun Zhao; Yongkun Gui; Haiqing Yan; Zhixin Yan; Ping Zhang; Li Liu; Li Chang; Jianlong Zhang
Journal:  Neurotox Res       Date:  2017-12-20       Impact factor: 3.911

3.  Correlation between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Diabetic Macular Edema.

Authors:  Eleni Dimitriou; Theodoros N Sergentanis; Vaia Lambadiari; George Theodossiadis; Panagiotis Theodossiadis; Irini Chatziralli
Journal:  J Diabetes Res       Date:  2021-08-13       Impact factor: 4.011

4.  Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.

Authors:  Sunny S Singh; Mardin Rashid; Aloysius G Lieverse; Florian Kronenberg; Claudia Lamina; Monique T Mulder; Yolanda B de Rijke; Eric J G Sijbrands; Mandy van Hoek
Journal:  Diabetologia       Date:  2020-03-09       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.